BDBM28260 1,3,4-oxadiazole substituted naphthyridine, 27::4-(7-{5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl}-8-hydroxy-1,6-naphthyridin-5-yl)piperazin-2-one
SMILES: Oc1c(nc(N2CCNC(=O)C2)c2cccnc12)-c1nnc(Cc2ccc(F)cc2)o1
InChI Key: InChIKey=DPSWMKPGUBLRDC-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
HIV-1 Integrase (Human immunodeficiency virus type 1) | BDBM28260![]() (1,3,4-oxadiazole substituted naphthyridine, 27 | 4...) | PDB MMDB UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 7 | n/a | n/a | n/a | n/a | 7.2 | 37 |
GSK | Assay Description Purified recombinant integrase was first combined in a complex with biotinylated donor DNA- streptavidin-coated SPA beads. The complex was preincubat... | Bioorg Med Chem Lett 19: 1807-10 (2009) Article DOI: 10.1016/j.bmcl.2009.01.089 BindingDB Entry DOI: 10.7270/Q2TH8K1R | |||||||||||
More data for this Ligand-Target Pair |